IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 2 filers reported holding IMPAX LABORATORIES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $351,000 | -2.5% | 18,066 | +1.9% | 0.00% | – |
| Q3 2017 | $360,000 | -98.9% | 17,731 | -97.4% | 0.00% | -100.0% |
| Q1 2015 | $31,574,000 | -25.0% | 673,653 | -49.3% | 0.03% | -25.6% |
| Q4 2014 | $42,101,000 | +34.4% | 1,328,930 | +0.6% | 0.04% | +34.5% |
| Q3 2014 | $31,328,000 | -39.3% | 1,321,280 | -23.2% | 0.03% | -38.3% |
| Q2 2014 | $51,625,000 | +38.3% | 1,721,415 | +21.9% | 0.05% | +30.6% |
| Q1 2014 | $37,316,000 | +35.5% | 1,412,410 | +28.9% | 0.04% | +33.3% |
| Q4 2013 | $27,537,000 | +101.1% | 1,095,327 | +64.1% | 0.03% | +92.9% |
| Q3 2013 | $13,690,000 | -20.2% | 667,488 | -22.4% | 0.01% | -26.3% |
| Q2 2013 | $17,157,000 | – | 859,985 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |